Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arribas

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Molecular Cell|May 7, 1999
A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surfaceJ Fernández-Larrea, A Merlos-Suárez, J M Ureña, et al.
Cancer Research|March 30, 1999
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cellsJ Codony-Servat, J Albanell, J C Lopez-Talavera, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|October 1, 1990
[Mitral endocarditis caused by group C beta-hemolytic Streptococcus (S. equisimilis)]F J Espinosa, F Dronda, J Arribas, et al.
British Journal of Haematology|December 28, 2016
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulationValentina Restelli, Micaela Vagni, Alberto J Arribas, et al.
The Journal of Biological Chemistry|May 10, 1996
Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitorsJ Arribas, L Coodly, P Vollmer, et al.
British Journal of Haematology|October 7, 2025
Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphomaNicolas Munz, Alberto J Arribas, Roberta Bordone Pittau, et al.
Cancer Research|June 19, 2001
Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cellsM A Molina, J Codony-Servat, J Albanell, et al.
Molecular Biology of the Cell|December 5, 2000
The carboxy-terminal cysteine of the tetraspanin L6 antigen is required for its interaction with SITAC, a novel PDZ proteinM Borrell-Pagès, J Fernández-Larrea, A Borroto, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 21, 2000
Atopy and pulmonary function abnormalities in children with a history of acute bronchiolitisJ Arribas, C Colás, A Sebastián, et al.
Journal of Applied Microbiology|November 13, 2019
Implications of grey zone results for routine hepatitis C virus screening with the ARCHITECT HCV-Ag assayJ Arribas, R Benito, R Cebollada, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Molecular Cell|May 7, 1999
A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surfaceJ Fernández-Larrea, A Merlos-Suárez, J M Ureña, et al.
Cancer Research|March 30, 1999
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cellsJ Codony-Servat, J Albanell, J C Lopez-Talavera, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|October 1, 1990
[Mitral endocarditis caused by group C beta-hemolytic Streptococcus (S. equisimilis)]F J Espinosa, F Dronda, J Arribas, et al.
British Journal of Haematology|December 28, 2016
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulationValentina Restelli, Micaela Vagni, Alberto J Arribas, et al.
The Journal of Biological Chemistry|May 10, 1996
Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitorsJ Arribas, L Coodly, P Vollmer, et al.
British Journal of Haematology|October 7, 2025
Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphomaNicolas Munz, Alberto J Arribas, Roberta Bordone Pittau, et al.
Cancer Research|June 19, 2001
Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cellsM A Molina, J Codony-Servat, J Albanell, et al.
Molecular Biology of the Cell|December 5, 2000
The carboxy-terminal cysteine of the tetraspanin L6 antigen is required for its interaction with SITAC, a novel PDZ proteinM Borrell-Pagès, J Fernández-Larrea, A Borroto, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 21, 2000
Atopy and pulmonary function abnormalities in children with a history of acute bronchiolitisJ Arribas, C Colás, A Sebastián, et al.
Journal of Applied Microbiology|November 13, 2019
Implications of grey zone results for routine hepatitis C virus screening with the ARCHITECT HCV-Ag assayJ Arribas, R Benito, R Cebollada, et al.
Pageof 12